
- BioPharm International-03-15-2018
- Volume 2018 eBook
- Issue 1
Good Quality Agreements Support Compliance with CGMP
Drug manufacturers can improve use of quality agreements in contract manufacturing.
FDA finalized its guidance on contract manufacturing,
In the months since FDA finalized this guidance, how has industry responded? Are manufacturers that establish contracts for specific manufacturing activities using quality agreements effectively? The answer is mixed; yes, many are, but there is room for improvement. In this article, the authors cover the scope and legal underpinnings of the guidance, as well as what FDA investigators may consider regarding a quality agreement during an inspection. The article also provides some examples of issues related to quality agreements that FDA has called out in warning letters since the guidance was finalized.
View other articles in
Article Details
BioPharm Internationalâ¨
eBook:
Outsourcing Resources 2018
Vol. 31â¨
March 2018â¨
Pages: 16–21
Citation
When referring to this article, please cite it as P. Katz et al., "Good Quality Agreements Support Compliance with CGMP,"
BioPharm International Outsourcing Resources eBook
(March 2018).
Articles in this issue
over 7 years ago
Quality Oversight During Sterile Filling Operationsover 7 years ago
Gaining Analytical Insight in the Development of Biologicsover 7 years ago
Contract Services Investment Updateover 7 years ago
Process Validation in Biologics Developmentover 7 years ago
Bigger is Better in Samsung's Approach to Biomanufacturingover 7 years ago
Choosing an Analytical Partner in Early Drug Developmentover 7 years ago
Outsourcing: Does Focus Pay Off?over 7 years ago
Avoiding Complete Response LettersNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.